Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline
Easily accessible blood-based biomarkers of AD may be linked to subsequent faster cognitive decline in the general older population, with patterns suggesting some heterogeneity across biomarkers and that individual characteristics may influence clinical interpretation.